Materials and Methods
Ofeight methods examined for measuring plasma hemoglobin in micromolarconcentration, all exhibited acceptable linearity, reproducibility, and concurrence except when specimens were icteric or Iipemic or contained methemoglobinor methemalbumin. Measurement of absorbance at 578 nm with an Allen correction permits precise assay of plasma oxyhemoglobinconcentration as low as 0.01 g/L (1 mg/dL, 016 Amol/L), unaffected by hyperlipidemiaor hyperbilirubinemia. Discrepancies between methods occurred in 11.6% of a consecutive series of 50 nonictenc patients' plasma specimens. Examination of absorption spectra is helpful when discrepancies are observed between methods. (4, 5) , derivative spectrophotometry (6-11), and chromogemc assays based on a peroxidase reaction with benzidine or benzidine derivatives (12-18), other chromogens (19-22), or chemiluminescence (23) . A modification of the Drabkin method has been proposed for microanalysis (24) . The purpose of this study was to reexamine and to compare several of these methods and determine how their results are influenced by such variables as icterus, lipemia, and the presence of other pigments.
healthy blood donors. Serum specimens were used to evaluate the effect of icterus or hyperlipemia on hemoglobin assay results. These sera were residual from specimens submitted to the Clinical Chemistry Laboratory for diagnostic tests. Other plasma specimens were obtained from outdated blood from the Mayo Clinic Blood Bank. For all healthy donor specimens, informed consent was obtained.
A Powell (26) and Fossati and Prencipe (27), respectively.
The effects of various concentrations of hemoglobin, bilirubin, and triglycerides on the hemoglobin assay were first tested by creating artificial mixtures of these three substances in predetermined
concentrations. Analytical recovery studies were then performed by adding hemoglobin in predetermined increments to native plasma specimensto which bilirubin or triglycerides or both had been added to predetermined values. This was done by use of serum specimens with high concentrations of bilirubin or triglycerides or both.
The effect of ceruloplasmun on hemoglobin assay results was tested by measuring plasma hemoglobin concentration in a plasma specimen that contained hemoglobin in an initial concentration of 0.50 gIL and was neither icteric nor turbid. The specimen was divided into two portions. To 0.7 mL of one was added 0.3 mL of isotonic saline; to 0.7 mL of the other was added 0.3 mL of the same NaCl solution but containing 7.68 mg of ceruloplasmun (from Sigma Chemical Co., St. Louis, MO). The hemoglobin concentration of each aliquot was then assayed by all eight methods.
Assay Methods
The following methods and their corresponding calculations were used for plasma hemoglobin assays. Unless otherwise stated, for all specimens that were diluted before the absorbance measurements, the dilution was 11-fold in Na2CO3, 0.942 molIL.
All spectrophotometric measurements were performed with a DU-7 spectrophotometer (Beckman Instruments, Glendale, CA). 
To solve these polynomials for the coefficients f1 through f6,we obtaineddatafrom 29 clinical specimens of plasma, including apparently normal plasma specimens and specimens with increased concentrations of hemoglobin or bilirubin or both. Total bilirubin concentration was determined independently by the diazotized sulfanilic acid method, and oxyhemoglobin concentration was determined by the BD or Kahn et a!. method because, of the methods we have examined, these assays for plasma oxyhemoglobin are least subject to technical variables and do not depend on absorbance measurements at 415,450, and 700 nm. Values for f1through f6
were determined by the least-squares method by using these data. The equations so derived were, for 11-folddiluted specimens, Second-derivative method (8). The second derivative of the absorbance was measured in the wavelength range 570 to 580 nm, where oxyhemoglobin has a narrow absorption peak that is well separated from the absorption maximum of bilirubin and where "noise" is minimal.
Most of the measurements were made on undilutedplasma. However, some specimens required dilution with isotonic saline for the second derivative to
This method is adapted from Crosby and Furth (12) , and tetramethylbenzidine is the chromogen. We add 5 L of plasma to a tube containing 1.0 mL of 1 g of tetramethylbenzidine in 100 mL of acetic acid (900 mL of glacial acid per liter), then mix well with 0.7 mL of H202 (10 mLJL) and incubate the sample for 20 mm. We then dilute the mixture with 10 mL of 100 mLIL acetic acid reagent, incubate for 10 mm, measure the absorbance at 660 nm, and read the hemoglobin concentration from a standard curve.
Data Analysis
Reproducibility (CV) of the assay results was determined, at several hemoglobin concentrations, by 30 replicate assays. Normal (reference) ranges were determined from the apparently healthy donors' plasma specimens. Assay results for 66 plasma specimens submitted to the laboratory specifically for hemoglobin or bilirubin measurement (16 icteric, 50 nonicteric) were compared for reproducibility in replicate assays.
Means and standard deviations for each method were computed. The observed agreement between each method and the peroxidase (Crosby-Furth) method was plotted by using cumulative frequency polygons of the differences in individual patients and also polygons of the absolute differences. Similar graphs compared each method with the Kahn method.
Spectral absorbance scans were obtained, usually in the range of 400 to 700 nm, to illustrate the principles of these assays or to resolve discrepancies that resulted from the presence of interfering pigments.
Results

Sensitivity and Reproducibility
For either pure hemoglobin solutions or plasma specimens with low concentrations of bilirubin and little or no turbidity, good agreement was observed among all eight methods. The BD method and the method of Kahn et al. showed the best sensitivity and reproducibility, both detecting plasma hemoglobin concentration as low as 0.01 gIL (the lowest concentration we tested). The peroxidase and second-derivative methods were insensitive to plasma hemoglobin in concentrations <0.04 g/L. Linearity was excellent for each of the eight methodsin the clinically important range of 0.08 to 2.00 gIL. Within this range, analytical recovery averaged 99% (SD 3.6%) without significant differences between methods.
Reproducibility was examined by 30 replicate assays by each of the methods at different plasma hemoglobin concentrations (Table 1) 
Agreement among Methods
Artificial
mixtures.
In studies of artificial mixtures, Seven methods showed essentially equivalent results for plasma specimensthatwere without icterus or turbidity ( Table 2 ). The peroxidase method was insensitive to a plasma hemoglobin concentration of 0.03 g/L but was satisfactory for quantifying greater concentrations of plasma hemoglobin.
When these different methods were compared in testing patients' specimens for plasma hemoglobin concentration, one or more methods yielded results that were discordant (as defined in Table 3 ) with the results of the other methods for 19 of 50 consecutive specimens. Discrepancies were most frequent in specimens with an increased concentration of plasma hemoglobin. The frequency and degree of discordance are shown in Table 3 for these 50 consecutive nonicteric plasma specimens, in which plasma hemoglobin concentrations ranged from 0 a Most of the variability in the peroxidase assays of these specimens was attilbutable to instnjment "noise" and deviations In cuvet absothance. Thus.
for mostof thesespecimens,the peroxidase assay result was -0.0 g/L. 5.51-6.00
The interval within which most assay resultsoccurred for each specimen. One specimenhadfour assay resultsin the consensus range0 to 0.10g/Land four results In the range 0.11to 0.25 giL This specimen was assigned to the former group on the basisof mean value of 0.08 g/L.
percentage of assay values outside the consensus range In the first column.
c The average deviation of assay results that were outside the consensus range from the average assay result for thosevalues that were within the consensus range. to 6.0 gIL. Altogether, 40 assay results (11%) deviated from the consensus ranges shown in Table 3 . These deviations ranged from 0.002 to 0.58 gIL, the largest deviation being a second-derivative assay result that was one-half the magnitude of the consensus mean.
Sixteen icteric clinical specimens (bilirubin >51.3 itmol/L) showedmarkedly discordant results for hemoglobin. Table 4 displays the effects of interference from high concentrations of either bilirubin or methemalbumin.
For 66 clinical specimens, the level of agreement among these eight methods is shown in Figures 1 and 2 . For technical reasons, such as insufficient specimen volume, only 26 of the 50 specimens were analyzed by all eight assay methods.
The effect of ceruloplasmin on plasma hemoglobin assay results is negligible, as shown in Table 5 
Representative Absorption Spectra
Representative absorption spectra are shown in Figure 3. Figure 3A is the typical curvefor oxyhemoglobin (0.30 gIL) in the absenceof bilirubin and of turbidity. Figure 3B is the absorption spectrum for a normal plasma specimen containing hemoglobin at 0.033 g/L and biirubinat 12.0 pmol/L. There is a high absorption peak at 415 nm (theclassic Soret band peak of oxyhemoglobin), a shoulder at 450 nm of lesserabsorbance that is due to bilirubin, and a tiny oxyhemoglobin peak at 578 nm. Figure 3C is the absorption spectrum for a plasma specimen that contained oxyhemoglobin, 0.03 g/L, and bilirubin, 330 zmol/L. The hemoglobin peaks appear to have been obliterated, although there is a deflection of the curve at 415 nm. In the undiluted specimen, a tiny oxyhemoglobin peak at 578 nm was still measurable by the BD and Kahn et al. methods. Figure 3D shows the absorption spectrum for a specimen with an increased hemoglobin concentration (0.24 g/L) and a normal bilirubin concentration (12.0 pmol/L). Figure 3E shows the absorption spectrum for a 10-folddiluted plasma specimen with increased concentrations of both hemoglobin (0.80 g/L) and bilirubin (313 mol/ L). Three oxyhemoglobin peaks are readily discernible at 415, 540, and 578 nm. There is also a prominent bilirubin peak at 450 nm. Figure 3F shows part of the absorption spectrum for a plasma specimen that contained oxyhemoglobin in normal concentration as well as methemalbumin, 72 jimol/L. The latter has an absorbance peak at 620 to 624 nm. Results for this specimen by various methods are shown in the third column of Table 4 . These results typify what we have observed for several specimensthat contained either methemoglobin or methemalbumin in addition to oxyhemoglobin. The only serum specimens we analyzed here were those deliberately selected to test the effect of high bilirubin concentration. IY-Kahnl,gIL (Figure 4, left) , imniunoglobulins, and other nonheme plasma proteins on the peroxidation of tetramethylbenzidine introduces a variable that may be difficult to control.
Levinson and Goldman ( X.nm X,nm In their study, at 4 mm after initiating the reaction, there was no effect of albumin on reaction rate in assays done at 37#{176}C.
When we reed absorbance at 24#{176}C, exactly 10 mm after the addition of acetic acid diluent, we apparently
